Is Aveanna Healthcare (AVAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aveanna Healthcare: Increasing Earnings And Delevering Focus Make It An Appealing Stock
Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private duty services and strategic M&A. AVAH trades at a low LTM P/E of 11.8x, reflecting its high leverage but also offering compelling value versus peers. Management targets reducing leverage below 3x, prioritizing cash-funded acquisitions and disciplined expansion to mitigate balance sheet risks.
4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Aveanna Healthcare (AVAH) Is Up 6.82% in One Week: What You Should Know
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Earnings Estimates Rising for Aveanna (AVAH): Will It Gain?
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AVAH Q2 Earnings Call Highlights Higher Growth Targets
Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred payers support expansion.
Aveanna Healthcare: Q2 Earnings Report Boosts The Stock And Reinforces My Buy Rating
Aveanna Healthcare Holdings delivered strong Q2 2026 results, beating earnings and revenue estimates and significantly raising full-year EBITDA and revenue guidance. AVAH's valuation remains attractive versus peers, with the lowest forward P/E multiples and leading EBITDA margin, despite a 60% stock price gain since March. Private Duty Services drive 83% of revenues, but gross margins declined across all segments; rapid revenue growth offset margin pressure, yet this trend warrants monitoring.
Aveanna Healthcare Q2 Earnings Call Highlights
Aveanna Healthcare NASDAQ: AVAH reported higher second-quarter revenue and adjusted EBITDA, supported by growth across its three operating divisions, improved reimbursement rates, increased volumes and operational efficiencies. The company also raised its full-year outlook and updated its long-term organic growth targets for its Private Duty Services and Home Health and Hospice businesses.
Aveanna (AVAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) Beats Q2 Earnings and Revenue Estimates
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.18 per share a year ago.
Is the Options Market Predicting a Spike in Aveanna Healthcare Stock?
Investors need to pay close attention to AVAH stock based on the movements in the options market lately.
